Clinical Trial Update: The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the preventative and therapeutic effects of ursodeoxycholic acid (UDCA) in Short Bowel Syndrome patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Short Bowel Syndrome | Phase 4 | Status: COMPLETED